Stay updated with breaking news from Nasdaq Dffn. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Equities researchers at StockNews.com started coverage on shares of Diffusion Pharmaceuticals (NASDAQ:DFFN – Get Rating) in a report released on Monday. The firm set a “hold” rating on the stock. Diffusion Pharmaceuticals Trading Down 3.5 % Shares of Diffusion Pharmaceuticals stock opened at $4.15 on Monday. The company has a market cap of $8.47 million, […]
Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN – Get Rating) was the target of a large drop in short interest in March. As of March 15th, there was short interest totalling 9,500 shares, a drop of 61.1% from the February 28th total of 24,400 shares. Approximately 0.5% of the company’s stock are short sold. Based on an average […]
StockNews.com began coverage on shares of Diffusion Pharmaceuticals (NASDAQ:DFFN – Get Rating) in a research report released on Sunday. The brokerage issued a hold rating on the stock. Diffusion Pharmaceuticals Stock Down 5.8 % NASDAQ DFFN opened at $4.86 on Friday. Diffusion Pharmaceuticals has a twelve month low of $4.64 and a twelve month high […]
Diffusion Pharmaceuticals (NASDAQ:DFFN – Get Rating) is set to post its quarterly earnings results on Friday, March 24th. Diffusion Pharmaceuticals Trading Down 3.3 % NASDAQ:DFFN traded down $0.19 during midday trading on Thursday, reaching $5.65. The company had a trading volume of 4,032 shares, compared to its average volume of 7,947. The firm has a […]
Diffusion Pharmaceuticals (NASDAQ:DFFN – Get Rating) is scheduled to post its quarterly earnings results on Friday, March 24th. Diffusion Pharmaceuticals Stock Performance Shares of DFFN stock traded down $0.19 on Thursday, hitting $5.65. The company had a trading volume of 4,032 shares, compared to its average volume of 7,947. The firm has a market cap […]